Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC)

Journal of Cancer

Volumn 2, Issue 1, 2011, Pages 347-349

  Bregni, Marco ^a   Ciceri, Fabio ^a   Peccatori, Jacopo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Advanced renal cell cancer; Allogeneic hematopoietic stem cell transplantation; Graft versus tumor

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; KIDNEY CARCINOMA;

EID: 84876022702     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.2.347     Document Type: Article

References (4)

1. Childs R, Chernoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 2000;343:750-758.
2. Takahashi Y, Harashima N, Kajigaya S, et al. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest 2008;118:1099-109.
3. Blaise D, Bay JO, Faucher C, et al. Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. Blood 2004;103:435-41.
4. Bregni M, Bernardi M, Servida P, et al. Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting. Bone Marrow Transplant 2009;44(4):237-42.